Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INNOVATE (VATE) Payables: 2009-2025

Historic Payables for INNOVATE (VATE) over the last 14 years, with Sep 2025 value amounting to $99.9 million.

  • INNOVATE's Payables rose 19.35% to $99.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $369.6 million, marking a year-over-year decrease of 15.98%. This contributed to the annual value of $84.8 million for FY2024, which is 40.66% down from last year.
  • INNOVATE's Payables amounted to $99.9 million in Q3 2025, which was up 24.56% from $80.2 million recorded in Q2 2025.
  • INNOVATE's Payables' 5-year high stood at $213.0 million during Q3 2022, with a 5-year trough of $70.2 million in Q1 2021.
  • Over the past 3 years, INNOVATE's median Payables value was $104.7 million (recorded in 2025), while the average stood at $119.5 million.
  • As far as peak fluctuations go, INNOVATE's Payables slumped by 79.01% in 2021, and later soared by 185.47% in 2022.
  • Quarterly analysis of 5 years shows INNOVATE's Payables stood at $179.2 million in 2021, then climbed by 13.00% to $202.5 million in 2022, then fell by 29.43% to $142.9 million in 2023, then crashed by 40.66% to $84.8 million in 2024, then increased by 19.35% to $99.9 million in 2025.
  • Its Payables stands at $99.9 million for Q3 2025, versus $80.2 million for Q2 2025 and $104.7 million for Q1 2025.